נמיביה - אנגלית - Namibia Medicines Regulatory Council

bayer (pty) ltd - meglumine amidotrizoate , sodium amidotrizoate - injection - each 20 ml ampoule contains meglumine amidotrizoate 10,4 g, sodium amidotrizoate 1,6 g (iodine content - 5,8 g)

נמיביה - אנגלית - Namibia Medicines Regulatory Council

bayer (pty) ltd - meglumine amidotrizoate, sodium amidotrizoate - injection - each 20 ml ampoule contains meglumine amidotrizoate 13,20 g, sodium amidotrizoate 2,00 g (iodine content - 7,4 g)

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - sodium amidotrizoate, quantity: 100 mg/ml; amidotrizoate meglumine, quantity: 660 mg/ml - injection, solution - excipient ingredients: water for injections; disodium edetate - intravenous and retrograde urography. computerised tomography. also for all angiographic examinations as well as for amniography, arthrography, intraoperative cholangiography, fistulography, hysterosalpingography, splenoportography, vesiculography and others. urografin is not to be used for myelography, ventriculography or cisternography since it is likely to provoke neurotoxic symptoms in the examinations.

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - gadopentetate dimeglumine, quantity: 469.01 mg/ml - injection, solution - excipient ingredients: pentetate meglumine; water for injections; meglumine - using magnetic resonance imaging (mri) dimeglumine gadopentetate provides contrast enhancement: . in intracranial and spinal lesions in adults and children with abnormal blood-brain barrier, or abnormal vascularity; . in whole body imaging in adult patients, including the neck region, the thoracic and abdominal space, the female breast, the pelvis and the musculoskeletal system. note: reliable enhancement is not provided in imaging the pancreas and the male reproductive organs (prostate, testis and penis). indications as at 30 august 1996: using magnetic resonance imaging (mri) dimeglumine gadopentetate provides contrast enhancement; in intracranial and spinal lesions in adults and children, including neonates and infants, with an abnormal blood-brain barrier, or abnormal vascularity; in whole body imaging in adult patients, including the neck region, the thoracic and abdominal space, the female breast, the pelvis and the musculoskeletal system. note: reliable enhancement is not provided in imaging the pan

אוסטרליה - אנגלית - Department of Health (Therapeutic Goods Administration)

bayer australia ltd - sodium amidotrizoate, quantity: 40 mg/ml; amidotrizoate meglumine, quantity: 260 mg/ml - injection, solution - excipient ingredients: water for injections; sodium calcium edetate - intravenous and retrograde urography. computerized tomography. also for all angiographic examinations as well as for aminography, arthrography, intraoperative cholangiography, fistulography, hysterosalpingography, splenoportography, vesiculography and others. urografin is not to be used for myelography, ventriculography of cisternography, since it is likely to provoke neurotoxic symptoms in these examinations.

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - meglumine amidotrizoate; sodium amidotrizoate - solution for infusion - 180mg/1ml ; 400mg/1ml

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - meglumine amidotrizoate; sodium amidotrizoate - solution for injection - 660mg/1ml ; 100mg/1ml

הממלכה המאוחדת - אנגלית - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - meglumine amidotrizoate; sodium amidotrizoate - solution for injection - 660mg/1ml ; 100mg/1ml

זימבאבווה - אנגלית - Medicines Control Authority

bayer (pty) ltd - meglumine amidotrizoate; sodium amidotrizoate - solution; injection - 0.52; 0.08 g/ml

טנזניה - אנגלית - Tanzania Medicinces & Medical Devices Authority

bayer east africa limited, kenya - meglumine amidotrizoate , sodium amidotrizoate - solution - -